Devices in the management of advanced, chronic heart failure (Q24630052)

Nature Reviews Cardiology

Europe PubMed Central

title

Devices in the management of advanced, chronic heart failure (English)

0 references

main subject

heart failure

0 references

chronic heart failure

1 reference

1

William T Abraham

0 references

author name string

Sakima A Smith

series ordinal

2

0 references

language of work or name

English

0 references

publication date

February 2013

0 references

published in

0 references

volume

10

0 references

issue

2

0 references

page(s)

98-110

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Use of a continuous-flow device in patients awaiting heart transplantation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Left ventricular assist device and drug therapy for the reversal of heart failure

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Impact of mitral regurgitation on the outcome of patients treated with CRT-D: data from the InSync ICD Italian Registry

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Telemedicine and remote management of patients with heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Current State of Ventricular Assist Devices

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Clinical, molecular, and genomic changes in response to a left ventricular assist device

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Aortic valve pathophysiology during left ventricular assist device support

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Recent national trends in readmission rates after heart failure hospitalization

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Rehospitalizations among patients in the Medicare fee-for-service program

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Clinical epidemiology of heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

The effect of cardiac resynchronization on morbidity and mortality in heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Acquired von Willebrand syndrome in aortic stenosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Cardiac resynchronization in chronic heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Long-term use of a left ventricular assist device for end-stage heart failure.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effect of carvedilol on survival in severe chronic heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Shear stress enhances the proteolysis of von Willebrand factor in normal plasma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Four chamber pacing in dilated cardiomyopathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Clinical use of the total artificial heart

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Remodeling and reparation of the cardiovascular system

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Implantable electrical left ventricular assist system: bridge to transplantation and the future

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Differential gene expression and genomic patient stratification following left ventricular assist device support

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Implantable left ventricular assist devices.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3753073

Lifetime Risk for Developing Congestive Heart Failure

30 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac-resynchronization therapy for the prevention of heart-failure events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac-resynchronization therapy in heart failure with narrow QRS complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Mitral regurgitation in patients with advanced systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Mechanisms of reduction of mitral regurgitation by cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Site of latest activation in patients eligible for cardiac resynchronization therapy: patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Biventricular pacemaker optimization guided by comprehensive echocardiography-preliminary observations regarding the effects on systolic and diastolic ventricular function and third heart sound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

HeartMate VE LVAS design enhancements and its impact on device reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

A compact highly efficient and low hemolytic centrifugal blood pump with a magnetically levitated impeller

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Progress of rotary blood pumps: Presidential Address, International Society for Rotary Blood Pumps 2006, Leuven, Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Advanced heart failure treated with continuous-flow left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

The Fourth INTERMACS Annual Report: 4,000 implants and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Biventricular assist device-induced right ventricular reverse structural and functional remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

INTERMACS database for durable devices for circulatory support: first annual report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

First experiences with a novel magnetically suspended axial flow left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Gastrointestinal bleeding with the HeartMate II left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Low thromboembolic risk for patients with the Heartmate II left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Implantable cardioverter defibrillators and cardiac resynchronisation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Multicenter evaluation of an intrapericardial left ventricular assist system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Intraventricular conduction delay: a prognostic marker in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Permanent Left Ventricular Pacing With Transvenous Leads Inserted Into The Coronary Veins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of Cardiac Resynchronization Therapy-Defibrillator Implantation on Health Status in Patients With Mild Versus Moderate Symptoms of Heart Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Comparison of cardiac resynchronization therapy outcomes in patients with New York Heart Association functional class I/II versus III/IV heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Results of the Predictors of Response to CRT (PROSPECT) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Clinical use of a cannula for left heart bypass without thoracotomy: experimental protection against fibrillation by left heart bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Preperitoneal placement of ventricular assist devices: an illustrated stepwise approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Successful Weaning and Explantation of the Heartmate II Left Ventricular Assist Device

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Chronic extra-aortic balloon counterpulsation: First-in-human pilot study in end-stage heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.178

Implantable circulatory support devices as a bridge to heart transplantation

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23229137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23229137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23229137